Interleukin-4 induces mouse cytomegalovirus interstitial pneumonia in a latent infection model

Kurume Medical Journal

Volumn 48, Issue 1, 2001, Pages 49-54

  Yonemitsu, Junko ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Interleukin 4; Interstitial pneumonia; Mouse cytomegalovirus

Indexed keywords

INTERLEUKIN 4; METHYLPREDNISOLONE; VIRUS DNA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BETAHERPESVIRINAE; DISEASE MODEL; HERPES VIRUS INFECTION; IMMUNOLOGY; INTERSTITIAL LUNG DISEASE; MALE; MOUSE; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, VIRAL; HERPESVIRIDAE INFECTIONS; INTERLEUKIN-4; LUNG DISEASES, INTERSTITIAL; MALE; METHYLPREDNISOLONE; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; VIRUS REPLICATION;

EID: 0035222674     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.48.49     Document Type: Article

References (40)

1. Drew WL. Cytomegalovirus infection in patients with AIDS. J Infect Dis 1988; 158:449-456.
2. Syndman DR, Rubin RH, and Werner BG. New developments in cytomegalovirus prevention and management. Am J Kidney Dis 1993; 21:217-228.
3. Weller TH. The cytomegalovirus: ubiquitous agents with protein clinical manifestations. N Eng J Med 1971; 285:203-214, 267-274.
4. Sonnabend J, Witkin SS, and Purtilo DT. Acquired immunodeficiency syndrome, opportunistic infections, and malignancies in male homosexuals. JAMA 1983; 249:2370-2374.
5. Blanks TA, and Rouse BT. Herpesviruses-immune escape artists? Clin Infec Dis 1992; 14:933-941.
6. Schmader KE, Rahija R, Porter KR, Daley G, and Hamilton JD. Aging and reactivation of latent murine cytomegalovirus. J Infect Dis 1992; 166:1403-1407.
7. Shanley JD. Host genetic factors influence murine cytomegalovirus lung infection and interstitial pneumonitis. J Gen Virol 1984; 65:2121-2128.
8. Zinkernagel RM, and Doherty PC. MHC restricted cytotoxic T cells; studies on the biological role of polymorphic major transplantation antigens determining T cell restriction specificity. Adv Immunol 1980; 27:51-177.
9. Allan JE, and Shellam GR. Genetic control of murine Cytomegalovirus infection: virus titers in resistant and susceptible strains of mice. Arch Virol 1984; 81:139-150.
10. Manning WC, Stoddart CA, Lagenaur LA, Abenes GB, and Mocarski ES. Cytomegalovirus determinant of replication in salivary glands. J Virol 1992; 66:3794-3802.
11. Scalzo AA, Fitzgerald NA, Wallace CR, Gibbons AE, Smart YC et al. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 1992; 149:581-589.
12. Gonczol E, Danczig E, Boldogh I, Toth T, and Vaczi L. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection. Acta Microbiologica Hungarica 1985; 32:39-47.
13. Jordan MC, Shanley JD, and Stevens JG. Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J Gen Virol 1977; 37:419-423.
14. Kurz S, Steffens HP, Mayer A, Harris JR, and Reddehase MJ. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 1997; 71:2980-2987.
15. Monika B, Liane D, Pero L, and Reddehase MJ. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. J Gen Virol 1994; 75:2329-2336.
16. Arnold RB, and John EC. Pathogenesis of pulmonary cytomegalovirus infection in immunosuppressed mice. J Infect Dis 1974; 129:677-689.
17. Shanley JD, Pesanti EL, and Kenneth MN. The pathogenesis of pneumonitis due to murine cytomegalovirus. J Infect Dis 1982; 146:388-396.
18. Shanley JD, and Pesanti EL. The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection. J Infect Dis 1985; 151:454-458.
19. Mayo DR, and Armstrong JA. Reactivation of murine cytomegalovirus by cyclophosphamide. Nature 1977; 267:721-723.
20. Yanping D, Zhonghua J, and Atherton SS. Dissemination and replication of MCMV after supraciliary inoculation in immunosuppressed BALB/c mice. Invest Ophthalmol Vis Sci 1994; 35:1124-1131.
21. Shanley JD, Thrall RS, and Forman SJ. Murine cytomegalovirus replication in the lungs of athymic BALB/c nude mice. J Infect Dis 1997; 175:309-315.
22. Quinnan GV, and Manischewitz JE. The role of natural killer cells and antibody-dependent cell mediated cytotoxicity during murine cytomegalovirus infection. J Exp Med 1979; 150:1549-1554.
23. Quinnan GV, Manischewitz JE, and Ennis FA. Role of cytotoxic T lymphocytes in murine cytomegalovirus infection. J Gen Virol 1980; 47:503-508.
24. Baiqing L, Milton DR, Turgut LA, Fusun OE, Chung WL et al. Disease-specific changes in γ δ T Cell repertoire and function in patients with pulmonary tuberculosis. J Immunol 1996; 157:4222-4229.
25. Celine DS, Andrea MC, Anthony AF, Richard JM, Barry RB et al. An anti-inflammatory role for γ δ T lymphocytes in acquired immunity to mycobacterium tuberculosis. J Immunol 1997; 158:1217-1221.
26. Fabrizio P, Miroslav M, Aaron P, Vittorio C, Guido S et al. In vivo γ T cell priming to mycobacterial antigens by primary mycobacterium tuberculosis infection and exposure to nonpeptidic ligands. Mol Med 1999; 5:471-476.
27. Julie D, Pierre M, and Annick L. Implication of γ δ T cells in the human immune response to cytomegalovirus. J Clin Invest 1999; 103:1437-1449.
28. Julie D, Pierre M, Frank B, Gabriel BM, Taupin JL et al. Major expansion of γ δ T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J Infect Disease 1999; 179:1-8.
29. Jordan MC. Interstitial pneumonia and subclinical infection after intranasal inoculation of murine cytomegalovirus. Infect Immun 1978; 21:275-280.
30. Ikeda T, Shimokata K, Daikoku T, Fukatsu T, Tsutsu Y et al. Pathogenesis of cytomegalovirus-associated pneumonitis in ICR mice: possible involvement of Superoxide radicals. Arch Virol 1992; 127:11-24.
31. Daynes RA, Dudley D, and Araneo BA. Regulation of murine lymphokine production in vivo: II. Dehydroepiandrosterone is a natural enhancer of IL-2 synthesis by help T cells. Eur J Immunol 1990; 20:793-802.
32. Dobbs CM, Feng N, Beck FM, and Sheridan JF. Neuroendocrine regulation of cytokine production during experimental infulenza viral infection: effects of restraint stress-induced elevation in endogenous corticosterone. J Immunol 1996; 157:1870-1877.
33. Northrop JP, Crabtree GR, and Matilla PS. Negative regulation of interleukin-2 transcription by the glucocorticoid receptor. J Exp Med 1992; 175:1235-1245.
34. Akdis CA, Blesken T, Akdis M, Alkan SS, Heusser CH et al. Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro. Eur J Immunol 1997; 27:2351-2357.
35. Daynes RA, and Araneo BA. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 1989; 19:2319-2325.
36. Daynes RA, and Araneo BA. Natural regulators of T-cell Lymphokine production in vivo. J Immunother 1992; 12:174-179.
37. Daynes RA, Meikle AW, and Araneo BA. Locally active steroid hormones may facilitate com partmental izati on of immunity by regulating the types of lymphokines produced by helper T cells. Res Immunol 1991; 142:40-45.
38. Ramirez F, Fowell DJ, Puklavec M, Simmonds S, and Mason D. Glucocorticoids promote a Th 2 cytokine response by CD4 + T cells in vitro. J Immunol 1996; 156:2406-2412.
39. Wu CY, Fargeas C, Nakajima T, and Delespesse G. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur J Immunol 1991; 21:2645-2647.
40. Ryuichi M, Makiko K, Herndon DN, Pollard RB, and Fujio S. Interleukin-12 protects thermally injured mice from herpes simplex virus type 1 infection. J Leukoc Bio 1996; 59:623-630.